Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
EBITDA as a percentage of revenue
3Y CAGR
+91.9%/yr
Annual compound
Percentile
P64
Within normal range
vs 3Y Ago
7.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.60% | +1062.8% |
| 2024 | 0.48% | -92.3% |
| 2023 | 6.28% | +693.0% |
| 2022 | 0.79% | +133.2% |
| 2021 | -2.38% | +42.7% |
| 2020 | -4.16% | +69.2% |
| 2019 | -13.49% | +32.9% |
| 2018 | -20.10% | -629.3% |
| 2017 | -2.76% | -177.9% |
| 2016 | 3.54% | - |